CTTH (CTT Pharmaceutical Holdings) Beginning Cash Position: $-0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CTT Pharmaceutical Holdings Beginning Cash Position?

CTT Pharmaceutical Holdings CTTH -0.13% Beginning Cash Position is $-0.00 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

CTT Pharmaceutical Holdings's Beginning Cash Position for the quarter that ended in Dec. 2025 was $-0.00 Mil.

CTT Pharmaceutical Holdings's quarterly Beginning Cash Position declined from Dec. 2015 ($0.08 Mil) to Dec. 2024 ($0.00 Mil) and declined from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($-0.00 Mil).

CTT Pharmaceutical Holdings's annual Beginning Cash Position declined from Dec. 2015 ($0.08 Mil) to Dec. 2024 ($0.00 Mil) and declined from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($-0.00 Mil).

CTT Pharmaceutical Holdings Beginning Cash Position Related Terms

CTT Pharmaceutical Holdings Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for CTT Pharmaceutical Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CTT Pharmaceutical Holdings Beginning Cash Position Chart

CTT Pharmaceutical Holdings Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 0.08 0.00 -0.00

CTT Pharmaceutical Holdings Semi-Annual Data
Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec24 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.08 0.00 -0.00

CTT Pharmaceutical Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $-0.00 Mil mean?
CTT Pharmaceutical Holdings (CTTH) has a Beginning Cash Position of $-0.00 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on CTT Pharmaceutical Holdings and its competitors.
Is CTT Pharmaceutical Holdings' Beginning Cash Position too high?
CTT Pharmaceutical Holdings' current Beginning Cash Position is $-0.00 Mil.
How does CTT Pharmaceutical Holdings' Beginning Cash Position compare to BUDZ and SBFM?
CTT Pharmaceutical Holdings' Beginning Cash Position of $-0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on CTT Pharmaceutical Holdings and its competitors. CTT Pharmaceutical Holdings's current Beginning Cash Position is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CTT Pharmaceutical Holdings stock overvalued right now?
CTT Pharmaceutical Holdings (CTTH) has a current Beginning Cash Position of $-0.00 Mil. The current Beginning Cash Position is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For CTT Pharmaceutical Holdings (CTTH), the current Beginning Cash Position is $-0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CTT Pharmaceutical Holdings Business Description

Address 3853 Northdale Boulevard, Suite 268, Tampa, FL, USA, 33624
CTT Pharmaceutical Holdings Inc specializes in drug delivery systems technology within the pharmaceutical industry. Its focus is on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The company's technology platform includes the development of oral delivery thin wafers to deliver treatment as an alternative to smoking and ingestion. This technology platform target both the human and veterinarian(pet) markets for treatment of many diseases. The Company believes that its technology will be one of the first to gain use in majorly markets such as pain management and smoking cessation. The Oral Thin Film formulation is protected by patents in the USA, Canada, Europe and many other countries across the world.